KCNK10 Protein

KCNK10 Protein — Potassium Two Pore Domain Channel Subfamily K Member 10

Introduction

KCNK10 (Potassium Two Pore Domain Channel Subfamily K Member 10), also known as TREK-2 (Two-pore domain weak inwardly rectifying potassium channel 2), is a member of the two-pore domain (K2P) potassium channel family. These channels play critical roles in regulating neuronal excitability, cellular metabolism, and responses to various physiological stresses. Emerging research suggests KCNK10 may have neuroprotective functions relevant to neurodegenerative diseases[@fink2000][@patel1998].

KCNK10 Protein — Potassium Two Pore Domain Channel Subfamily K Member 10

Introduction

KCNK10 (Potassium Two Pore Domain Channel Subfamily K Member 10), also known as TREK-2 (Two-pore domain weak inwardly rectifying potassium channel 2), is a member of the two-pore domain (K2P) potassium channel family. These channels play critical roles in regulating neuronal excitability, cellular metabolism, and responses to various physiological stresses. Emerging research suggests KCNK10 may have neuroprotective functions relevant to neurodegenerative diseases[@fink2000][@patel1998].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCNK10 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Potassium Two Pore Domain Channel Subfamily K Member 10 (KCNK10/TREK-2)</td></tr>
<tr><td><strong>Gene</strong></td><td>[KCNK10](/genes/kcnk10)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NP96](https://www.uniprot.org/uniprot/Q9NP96)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~56 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>K2P channel (TREK subfamily)</td></tr>
<tr><td><strong>Expression</strong></td><td>Brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia), kidney</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
</div>

Structure

KCNK10 possesses the characteristic K2P channel architecture:

• Four transmembrane segments: Two pore-forming domains (P1 and P2)
• Two selectivity filter motifs: Characteristic sequence for K+ selectivity (GGGX)
• N-terminal and C-terminal domains: Intracellular regulatory regions
• Two pore loops: Form the K+ selectivity filter
• C-terminal regulatory tail: Contains sites for modulation by lipids and kinases

Normal Function

Neuronal Excitability

• Background K+ conductance: Provides outward rectifying K+ current that stabilizes resting membrane potential
• Neuronal firing: Modulates action potential threshold and frequency
• Hyperpolarization: Helps maintain negative resting membrane potential
• Integration of synaptic inputs: Shapes postsynaptic responses

Metabolic Sensing

• Energy status: Channels respond to cellular metabolic state
• Oxygen sensing: Modulate responses to hypoxia
• pH regulation: Sensitive to intracellular and extracellular pH
• Glucose sensing: Respond to metabolic changes in [neurons](/entities/neurons)

Neuroprotection

• Ischemia response: Activated during oxygen-glucose deprivation
• Preconditioning: Channel activation mediates ischemic preconditioning
• Anti-excitotoxic: Protects against glutamate-induced excitotoxicity
• Anti-apoptotic: Prevents programmed cell death pathways

Role in Neurodegeneration

Alzheimer's Disease

• [Amyloid-beta](/proteins/amyloid-beta) effects: Aβ oligomers modulate KCNK10 activity
• Calcium homeostasis: Influences Ca2+ signaling in neurons
• Neuronal hyperexcitability: Dysregulation may contribute to network dysfunction
• Therapeutic potential: KCNK10 activators may be neuroprotective[@liu2019]
• Circadian function: Links to circadian rhythm disruption in AD

Parkinson's Disease

• Dopaminergic neurons: Expression in substantia nigra pars compacta
• Metabolic stress: Channels protect against mitochondrial dysfunction
• Oxidative stress: Response to [ROS](/entities/reactive-oxygen-species) in dopaminergic neurons
• Mitochondrial dysfunction: May be impaired in PD
• Motor control: Dysregulation affects basal ganglia circuitry

Therapeutic Implications

Channel Modulators

• Activators: Flavanoids, lysophospholipids, volatile anesthetics
• Inhibitors: Ruthenium red, quinine derivatives
• Physiological activators: Mechanical stretch, heat, acidic pH

Drug Development

• Neuroprotective strategies: Developing selective KCNK10 activators
• [Blood-brain barrier](/entities/blood-brain-barrier) penetration: Critical challenge for CNS drugs
• Selectivity: Targeting specific K2P subtypes
• Disease-modifying potential: Modulating channel activity to protect neurons

See Also

• [KCNK10 Gene](/genes/kcnk10)
• [Potassium Channels in Neurodegeneration](/mechanisms/potassium-channels-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Substantia Nigra Dopamine Neurons](/cell-types/substantia-nigra-dopamine-parkinsons)

References